Toggle navigation
About
Our People
Scientific Advisory Board
Partners and Distributors
Corporate Directory
Corporate Governance
COVID-19: Information for People Using Bronchitol
Product Pipeline
Drug Discovery
Amine Oxidase Platform
Oral pan-LOX Inhibitor (PXS-5505)
Topical pan-LOX Inhibitor (PXS-6302)
SSAO Inhibitor (PXS-4728)
LOXL2 Inhibitors (PXS-5382)
Other Amine Oxidase Inhibitor Programs
Other Pipeline Assets
Orbital® Dry Powder Inhaler
Publications & Posters
Patents
Approved Products
Manufacturing Facilities
Bronchitol®
Cystic Fibrosis
Clinical Trials
Publications
Patents
Partners and Distributors
COVID-19: Information for People Using Bronchitol
Aridol®
Asthma
Clinical Trials
Publications
Patents
Distributors
News
Patients & Prescribers
Contact
Media
Follow us
Investor Centre
Investor Centre
News
ASX Announcements
Quarterly Updates
Annual and Half Year Reports
Investor Presentations
Shareholder Services
Upcoming Events
Analyst Coverage
Major Shareholders
Corporate Governance
Subscribe to our emails or follow us
Videos and Podcasts
News Feeds
News Feeds
News Feeds
All News
All Pharmaxis News
Annual Reports
ASX Announcements
Investor Presentations
Quarterly Updates
